https://www.selleckchem.com/pr....oducts/d-lin-mc3-dma
5%) dMMR tumors (p less then 0.0001). Survival analyses revealed significant correlations between MMR-proficient (pMMR), PTEN expression, and a better outcome. The positive predictive value of PTEN-retained status for pMMR ranged from 94.6% in estrogen receptor (ER)+/HER2- tumors to 100% in HER2-amplified and ER-/HER2- cases. We propose a novel diagnostic algorithm where PTEN expression analysis can be employed to identify pMMR breast cancers.Fluorescent probes offer great potential to identify and treat surgical tumors by clinici
Like
Comment
Share
